drugset / Trial / NCT00131482

A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist

NCT00131482 ↗

Phase 2 Terminated 274 enrolled Capstone Therapeutics
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety of Chrysalin, also known as TP508, and to determine the effectiveness of four doses of Chrysalin for treating broken wrists in adults.

Timeline

Start
2004-11
Primary completion
2007-03
Completion
2007-03

Outcome

Outcome not reported

Stopped: “Treatment with Chrysalin did not demonstrate benefit compared to placebo.”

Drugs

EvaluationDrugModalityDoseRoute
Subject RUSALATIDE Peptide 1 ug Other
Subject RUSALATIDE Peptide 3 ug Other
Subject RUSALATIDE Peptide 10 ug Other
Subject RUSALATIDE Peptide 30 ug Other

Indications

No indication recorded.